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CHF/Cardiac nonCHF/Cardiac noncardiac
N 30 26 90
Age 63 (4971) 67 (6072) 63(2971)
Sex (% male) 37 58 60
Initial Rhythm N(%)
vrNF 7 (25) 11 (44) 24 (27)
Asystole 6 (21.4) 6(24) 33 (37.5)
Bradycardia 5 (17.9) 2 (8) 6(6.8)
EMD 6 (21.4) 1(4) 13(148)
Other 4 (14.3) 5 (20) 12(136)
ROSC 21 (70) 13 (50) 51 (567)
Survival to D/C 1(3.3) 4 (15.4) 2 (2.2)
Results: group A group B
ATP-tested yes no
patients (n) 18 48
VT episodes 532 491
ATP-termination 468 430
ATP unsuccessfull 29 41
VT-acceleration 35(6.6%) 20 (4.7%)
AlP-success rate 88% 88%
Conclusion: The autodecremental ramp is a safe and effective antitachy-
cardia pacing mode for terminating spontaneous ventricular tachycardias in
88% regardless of the result of the pre-discharge test.
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Patients with nonCHF/Cardiac disease had a higher ROSC than patients
with CHF and noncardiac diseases (p = 0.016). In summary, patients with
CHF often experience cardiopulmonary arrest with bradycardic or EMD ar-
rests. Although patients with CHF are resuscitated with a high degree of suc-
cess their in-hospital survival was low. Furthermore, the high rate of brady-
cardic and EMD arrests may explain the low in-hospital survival rates.
Implantation of a Single-Lead Unipolar
Transvenous Cardioverter/Defibrillatior (ICD)
Under Local Anesthesia
Therapy A B C D global p
PCl/No B 91/7 81/7 91/15 81/15
Allvr 68% 46% 85% 61% 69% <0.001
VTCL < 350· 82% 14% 44% 38% 47% 0.03
VTCl> 350 73% 100% 91% 86% 90% ns
Burst antitachycardia pacing (ATP) is higly efficacious for termination
of monomorphic ventricular tachycardia (MVT). Since several pacing se-
quences are usually programmed as a single therapy. optimal programming
is presently unknown. In 40 patients (P) with MVT and a 3rd generation AICD,
4 burst ATP were prospectively compared (as a first single ATP) during follow-
up in a randomized design crossing over every 2-3 months. Burst ATP modes
(A to D) were defined by pacing cycle length (PCl, as % of VTCl) and num-
ber of beats (No B) (Table). A second ATP zone was programmed in a non
selected way in all patients.
Results (Table): 374 episodes (317 considered MVT) received ATP thera-
pies in 23 patients. RR intervals could be retrieved for MVT-Cl analysis in
168 episodes. Succes rate of combined first (randomized) and second (non
selected) therapies was 92%. Acceleration rate estimation was 2%.
Ramdomized Prospective Comparison of Four
Burst Pacing Algorithms for Spontaneous
Ventricular Tachycardia
Rafael Peinado, Jesus Almendral. Teresa Rius. Angel Moya. Angel Arenal.
Julian Villacastin. Jose L. Merino, Olga Medina. Jesus Ma Alday. Agustin Pastor,
Jose Ormaetxe. Hospital G. Maranon and Hospital If. Hebron, Madrid and Barcelona,
Spain
Gunter Stix. Anahit Anvari. Martin Grabenwoger, Susanne Asenbaum.
Zeynep Turel, Gerald Maurer. Hervvig Schmidinger. OepartmentofCardiology,
University of Vienna, Austria
The purpose of this study was to prospectively evaluate single-lead unipolar
transvenous ICD implantation under local anesthesia and defibrillator thresh-
old testing under mild sedation.
In 12 consecutive patients (mean age. 61 ± 10 years) transvenous ICD im-
plantation was performed (9 patients had ischemic heart disease. 3 patients
dilated cardiomyopathy). The presenting arrhythmia was ventricular fibrilla-
tion in 4 patients. and monomorphic ventricular tachycardia in 8 patients.
Mean lVEF was 26 ± 11 %. A single-lead unipolar transvenous ICD with
biphasic defibrillation pulse was implanted subpectorally in all patients un-
der local anesthesia with 1% lidocaine. During defibrillation threshold (OFT)
testing sedation was applied with 11.5 ± 5.1 mg (0.14 ± 0.05 mglkg) mi-
dazolam. For DFT determination 5.8 ± 1.3 episodes of ventricular fibrillation
(mean total ventricular fibrillation time 52.4 ± 14.7 seconds) were induced.
Mean OFT was 12.8 ± 4.3 J. mean duration of the implantation procedure
was 58 ± 13 minutes. Heart rate. mean arterial blood pressure. and arterial
oxygen saturation were not significantly different before and after DFT deter-
mination. One patient had moderate pain during DFT testing. and 3 patients
had mild pain during the surgical procedure. Symptoms during the proce-
dure were evaluated using a standardized questionnaire. Severe feeling of
panic and surprise, and discomfort of moderate degree was reported by 2
patients. There were no complications. Hospital length of stay: all patients
were discharged on the second postoperative day. Postimplant ICD testing
was performed successfully without sedation 35 ± 1.4 days after ICD im-
plantation, in 6 patients as an outpatient procedure.
Conclusions: Single-lead unipolar transvenous ICD systems can safely
be implanted under local anesthesia and mild sedation during defibrillation
threshold testing. The procedure is well tolerated.
• Cl < 350: group of Mvr with Cl < 350 ms. 0 Cl > 350: Mvr with Cl > 350 ms
Conclusions: 1. Efficacy of the tested burst pacing modes differs signifi-
cantly, at least in fast VT. 2. Contrary to what could be expected. "less agres-
sive" bursts seem to be more efficacious, even in fast VT.
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Cerebral and overall performance after successful resuscitation is an impor-
tant measure of its success. To evaluate resuscitation attempts in adults (age
:0: 18 years) by the 24-hrs resuscitation team in our hospital (1,032 beds;
27,500 admissions/years), we prospectively collected data from resuscita-
tion forms and retrospectively from medical records. Performance was as-
sessed retrospectively by means of the Cerebral and Overall Performance
Categories (CPC/OPC).
Results: A total of 1205 calls were received from June 1988 up to Jan-
uary 1994 (the emergency room and general wards always call upon the
team, CCU/ICU only when intubation is required). 717/1205 calls were con-
firmed arrests in 675 adults (mean age 58, 43% >70 years). Resuscitation
was not attempted in 10 arrests. Return of spontaneous circulation occurred
in 347/717 arrests (49%). followed by transfer to the ICU or CCU. Of the 347
initial survivors 93 (27%) died within 24 hrs. and another 138 (40%) died later
during their hospital stay. 101 (15%) pts (38% > 70 years) were discharged
from the hospital alive. VFNT as initial rhythm was present in 60 (60%) sur-
vivors and ischaemic heart disease (ICD 41 0-414)was diagnosed in 40 (40%)
survivors.
Outcome performance was assessed at the time of discharge. Good
outcome: CPC1, 90 pts (90%); OPC1, 78 (78%); Moderate disabilities:
CPC2. 4 pts (4%); OPC2, 14 pts (14%); Severely disabledlvegetative state:
CPC/OPC3-4, 7 pts (7%). A total of 36 pts (36%) died after discharge. of
which 19 (53%) died within the first year.
Conclusion: Survivors after of in-hospital circulatory arrest have a good
prognosis in terms of cerebral and overall performance, but long term suc-
cesses are limited.
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The value of testing antitachycardia pacing (ATP) for the termination of
ventricular tachycardias (VT) in implantable defibrillators was evaluated in
a prospective trial. Pre-discharge testing of antitachycardia pacing was
attempted in 66 consecutive patients (pts) with non-thoracotomy third-
generation implantable cardioverter-defibrillators (ICD). VT's could be in-
duced in 18 pts (group A: 14 CAD, 3 DCM. 1 other) and were terminated
by ATP at the pre-discharge testing at least twice. In 48 pts (group B: 30
CAD,9 DCM, 9 others) the effectivity of ATP could not be tested due to non-
inducible VT ATP was programmed in both groups as an autodecremental
ramp with 81 % of the tachycardia cycle length and up to 4 sequences with
8 to 11 stimuli. The mean follow-up was 10 months
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